跳至主要内容
临床试验/NCT01026675
NCT01026675已完成不适用

Early Screening for Gestational Diabetes Mellitus

Université de Sherbrooke1 个研究点 分布在 1 个国家目标入组 1,442 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,442
试验地点
1
主要终点
oral glucose challenge test plasma glucose value

研究概览

简要总结

The working hypothesis of this proposal is that screening for gestational diabetes mellitus as early as the 1st trimester is efficient for detecting the forthcoming presence or absence of gestational diabetes mellitus. The investigators long-term goal is the prevention of gestational diabetes mellitus onset i.e. the prevention of progression to gestational diabetes mellitus, in order to enable delivery of appropriate counselling, diagnostics and treatment for pregnant women, as well as to improve pregnancy outcomes. Therefore, robust 1st trimester screening criteria is needed.

The overall objective of this proposal is to determine an accurate and valid 1st trimester 1h post 50g oral glucose challenge test plasma glucose cut-off value that is predictive of gestational diabetes mellitus onset.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age > 18 yrs
  • Gestational age between 6 and 13 weeks from last menstrual period,
  • Alcohol < 2 drinks/day
  • Not involved in regular high intensity physical activity
  • Singleton pregnancy
  • Otherwise good health status.

排除标准

  • Type 1 or type 2 diabetes
  • Taking drugs interfering with glucose metabolism

结局指标

主要结局

oral glucose challenge test plasma glucose value

时间窗: 6-13 weeks

the sensitivity, specificity, positive and negative predictive values of oral glucose challenge test plasma glucose \>= 7.8 mmol/L during the 1st trimester (6-13 weeks of gestation), as compared with fasting 75g glucose oral glucose tolerance test performed between the 24th and 28th weeks of gestation (the Canadian Diabetes Association - CDA gold standard).

次要结局

  • oral glucose challenge test plasma glucose cut-off value(6-13 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jean-Luc Ardilouze

Endocrinologist, researcher

Université de Sherbrooke

研究点 (1)

Loading locations...

相似试验